- Home
- RCKT vs IHS Comparison
RCKT vs IHS Comparison
Compare RCKT & IHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- IHS
- Stock Information
- Founded
- RCKT 1999
- IHS 2001
- Country
- RCKT United States
- IHS United Kingdom
- Employees
- RCKT N/A
- IHS N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- IHS Telecommunications Equipment
- Sector
- RCKT Health Care
- IHS Telecommunications
- Exchange
- RCKT Nasdaq
- IHS Nasdaq
- Market Cap
- RCKT 764.5M
- IHS 1.6B
- IPO Year
- RCKT N/A
- IHS 2021
- Fundamental
- Price
- RCKT $7.18
- IHS $5.71
- Analyst Decision
- RCKT Strong Buy
- IHS Strong Buy
- Analyst Count
- RCKT 10
- IHS 5
- Target Price
- RCKT $44.10
- IHS $7.60
- AVG Volume (30 Days)
- RCKT 3.2M
- IHS 860.4K
- Earning Date
- RCKT 05-08-2025
- IHS 05-16-2025
- Dividend Yield
- RCKT N/A
- IHS N/A
- EPS Growth
- RCKT N/A
- IHS N/A
- EPS
- RCKT N/A
- IHS N/A
- Revenue
- RCKT N/A
- IHS $1,711,225,000.00
- Revenue This Year
- RCKT N/A
- IHS $0.51
- Revenue Next Year
- RCKT N/A
- IHS $6.34
- P/E Ratio
- RCKT N/A
- IHS N/A
- Revenue Growth
- RCKT N/A
- IHS N/A
- 52 Week Low
- RCKT $4.55
- IHS $2.44
- 52 Week High
- RCKT $26.98
- IHS $5.75
- Technical
- Relative Strength Index (RSI)
- RCKT 46.92
- IHS 67.76
- Support Level
- RCKT $6.21
- IHS $4.85
- Resistance Level
- RCKT $8.26
- IHS $5.09
- Average True Range (ATR)
- RCKT 0.58
- IHS 0.26
- MACD
- RCKT 0.03
- IHS 0.08
- Stochastic Oscillator
- RCKT 28.05
- IHS 78.11
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About IHS IHS Holding Limited
IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.